Groups with a variety of views on tweaking aspects of the Trade-Related Aspects of Intellectual Property Rights Agreement for COVID-19 vaccines can agree on one thing: They’re unhappy with the compromise outcome produced by the World Trade Organization at its 12th ministerial last week. The American Enterprise Institute on Tuesday hosted a panel discussion titled “The Debate over Intellectual Property Protections for COVID-19 Vaccines after one year,” which featured discontented responses from both sides of the TRIPS question. “I think...